Literature DB >> 8810499

A highly vancomycin-resistant laboratory mutant of Staphylococcus aureus.

K Sieradzki1, A Tomasz.   

Abstract

A resistant mutant with vancomycin MIC of 100 micrograms/ml was isolated relatively easily through step pressure in the laboratory from a Staphylococcus aureus strain with initial MIC of 1.5 micrograms/ml for the antibiotic. Upon addition of vancomycin (50 micrograms/ml) to the growth medium mass increase of the culture and peptidoglycan synthesis continued but cell division (daughter cell separation), cell wall turnover and autolysis were inhibited, resulting in the production of multicellular clumps of bacteria. Parallel with the increase of culture density, the concentration of vancomycin measured both by biological activity and by HPLC gradually declined in the culture medium. Cell division and wall turnover of the culture resumed with the production of cells of normal morphology at the time when the concentration of the drug in the medium decreased below 0.5-1.0 micrograms/ml. There was no detectable change in the antibiotic concentration in the culture medium during growth of a vancomycin-resistant (vanA-positive) strain of Enterococcus faecium and an intrinsically vancomycin-resistant strain of Leuconostoc. The vancomycin-resistant staphylococcal mutant gave no signal with the vanA or vanB DNA probes and contained no detectable D-lactate terminating cell wall precursors. The biochemical mechanism and clinical significance of such glycopeptide-resistant mutants remained to be established.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8810499     DOI: 10.1111/j.1574-6968.1996.tb08424.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  17 in total

1.  Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates.

Authors:  S Boyle-Vavra; S K Berke; J C Lee; R S Daum
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Structural and topological differences between a glycopeptide-intermediate clinical strain and glycopeptide-susceptible strains of Staphylococcus aureus revealed by atomic force microscopy.

Authors:  S Boyle-Vavra; J Hahm; S J Sibener; R S Daum
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

3.  Lack of evidence for involvement of hypermutability in emergence of vancomycin-intermediate Staphylococcus aureus.

Authors:  Alexander J O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

4.  Intact mutS in laboratory-derived and clinical glycopeptide-intermediate Staphylococcus aureus strains.

Authors:  Arunachalam Muthaiyan; Radheshyam K Jayaswal; Brian J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

Review 5.  Peptidoglycan remodeling by the coordinated action of multispecific enzymes.

Authors:  Laura Alvarez; Akbar Espaillat; Juan A Hermoso; Miguel A de Pedro; Felipe Cava
Journal:  Microb Drug Resist       Date:  2014-05-05       Impact factor: 3.431

6.  An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus.

Authors:  Franziska Schaaff; Andrea Reipert; Gabriele Bierbaum
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus.

Authors:  K Sieradzki; A Tomasz
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

8.  Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate.

Authors:  S Boyle-Vavra; B L de Jonge; C C Ebert; R S Daum
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

9.  Role of murE in the Expression of beta-lactam antibiotic resistance in Staphylococcus aureus.

Authors:  S Gardete; A M Ludovice; R G Sobral; S R Filipe; H de Lencastre; A Tomasz
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

Review 10.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.